Tonix Pharmaceuticals (TNXP) Stock Climbs On COVID-19 News

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is screaming for the top in the market this morning, and for good reason. The company announced COVID-19-related news, exciting investors. Here’s what’s going on: Tonix Pharmaceuticals Announces A COVID-19 Licensing Deal In the press release, Tonix Pharmaceuticals said that it entered into an exclusive worldwide licensing agreement with … Read more

TNXP Stock: This Could Be the Next Big Short Squeez

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is making its way up in the market this morning, and for good reason. The company announced positive data from its COVID-19 vaccine development program. Here’s what’s happening: Skip to What You Want to Read Tonix Pharmaceuticals Announces Positive Data Management Commentary This Could Be a Short Squeeze in … Read more

Tonix Pharmaceuticals (TNXP) Stock: Gaining On Expanded Phase 3 Program

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is making a run for the top in the market this morning, and for good reason. The comapny announced that it would be expanding a late-stage clinical development program. As you could imagine, the news excited investors, sending the stock on a run for the top. Today, we’ll talk … Read more

Tonix Pharmaceuticals (TNXP) Stock: Gaining On Patient Enrollment

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is flying early on in the trading session this morning, and for good reason. The company announced its first patient enrollment in a Phase 3 clinical trial. Of course, the news excited investors who are pushing the stock on a run for the top. Today, we’ll talk about: The … Read more

Tonix Pharmaceuticals (TNXP) Stock: Climbing On Patent News

Tonix Pharmaceuticals TNXP Stock News

After announcing news surrounding a European patent late yesterday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is flying in the market this morning. The patent protects TNX-601, a key treatment that the company has under development. So, the gains that we’re seeing in the market this morning come as no surprise. Today, we’ll talk about: The … Read more

Tonix Pharmaceuticals (TNXP) Stock: Here’s What’s Going On

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is having an incredibly strong start to the trading session today. However, if you go digging for news via SEC filing or press release, you’re not going to find any. The company hasn’t released anything. Today, we’ll talk about: Why the stock may be moving; what we’re seeing from … Read more

Tonix Pharmaceuticals (TNXP) Stock: Tanks On S-1 Filing

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is having an incredibly rough start to the trading session in the pre-market hours this morning. After digging into the news, you’ll see that the company hasn’t issued any press releases. So, what’s the deal? The declines seem to surround an offering of common stock. Today, we’ll talk about: … Read more

Tonix Pharmaceuticals (TNXP) Stock: Flying On Clinical Data

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is having an incredibly strong start to the trading session this morning afte rthe company announced a poster presentation and clinical data. Of course, the news excited investors, sending the stock screaming for the top. Today, we’ll talk about: The poster presentation; what we’re seeing from TNXP as a … Read more

Tonix Pharmaceuticals Holding Corp (TNXP) Stock: Headed Up On FDA Clearance

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is having a relatively strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that the United States Food and Drug Administration has cleared an IND that allows for the initiation of a Phase 2 clinical study. Of course, this … Read more